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The formation of multiple cysts in one or several organs is a characteristic of several human inher-
ited diseases. Recent research suggests that problems in planar cell polarity may be the common
denominator in polycystic diseases. Mutations in at least two genes are linked to autosomal domi-
nant polycystic liver disease (PCLD), PRKCSH and SEC63. A recent study linked PRKCSH to the signal-
ing- and cytoskeletal adaptor-component b-catenin. In a yeast two hybrid screen we identiﬁed the
cytosolic protein nucleoredoxin (NRX) as an interaction partner of human Sec63. Since NRX is
involved in the Wnt signaling pathways, we characterized this interaction. Thus, Sec63 is linked
to the Wnt signaling pathways and this interaction may be the reason why mutations in SEC63
can lead to PCLD.
Structured summary:
Sec63 physically interacts with NRX by two hybrid (View interaction)
NRX binds to Sec63 by peptide array (View Interaction 1, 2)
Sec63 binds to NRX by pull down (View interaction)
Sec63 binds to NRX by peptide array (View Interaction 1, 2, 3)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction that these problems cause alterations in planar cell polarity andVarious human organs can develop numerous cysts, i.e. ﬂuid-
ﬁlled sacs, which are, typically formed by a certain cell type [1].
The classical example of this type of human inherited disease is
autosomal polycystic kidney disease (ADPKD; OMIM 173900). It
is characterized by numerous renal cysts as well as additional ex-
tra-renal manifestations, such as cysts in the liver bile ducts. Muta-
tions in two genes were linked to ADPKD: PKD1 codes for
polycystin 1 (PC1), a plasma membrane resident receptor [2], and
PKD2 codes for polycystin 2 (PC2) or TRPP2, a member of the tran-
sient receptor potential (TRP) family that resides in the endoplas-
mic reticulum (ER) and the plasma membrane [3–5]. The two
polycystins interact in the plasma membrane and may form a sig-
naling complex [5–8]. Recent research on ADPKD suggests PKD
mutations result in problems in downstream signaling- as well
as cell–cell adhesion-components, most notably b-catenin, andchemical Societies. Published by E
utathione S-transferase; NRX,
crzim@uniklinikum-saarland.tubular morphogenesis that, eventually, result in cyst formation
(summarized in [1]).
Autosomal dominant polycystic liver disease (ADPLD or PCLD,
OMIM 174050) is a ADPKD-related human disorder, characterized
by the progressive development of biliary epithelial liver cysts
[1,9]. On the genetic level, ADPLD is heterogeneous involving at
least two different genes: PRKCSH, encoding the b-subunit of gluco-
sidase II (also termed hepatocystin) which is a resident protein of
the ER lumen and is involved in the folding of glycoproteins [10],
and SEC63, which codes for the Sec63 protein that resides in the
ER membrane and may be involved in protein transport into the
ER (together with its interaction partners, the Sec61 complex and
Sec62 protein) [11–18]. A loss of function was postulated for all
cases described with PRKCSH- and SEC63-mutations. Although
not investigated in ADPLD, the disease is currently explained by
a two-hit mechanism. Accordingly, patients with one inherited
mutant allele and one wild type allele may at some point lose
the second allele in some cholangiocytes through somatic muta-
tion. Subsequently, the progeny of these cells develop into cysts.
The mechanism of cyst development is still unclear. A plausible
scenario would be that hepatocystin and Sec63 are essential for
the biogenesis of a single protein or a set of proteins that arelsevier B.V. All rights reserved.
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in the absence of hepatocystin and Sec63 functions, these proteins
do not reach their functional location. Somehow, this could result
in a proliferative advantage for the progeny of the respective cells
and/or in alterations in planar cell polarity and morphogenesis.
However, alternative models have to be considered (see below).
Although ADPLD patients hardly ever suffer from other polycystic
organ disorders, the etiologies of ADPKD and ADPLD may be re-
lated [1].
To obtain further insights into the physiological and patho-
physiological functions of human Sec63, we searched for additional
interaction partners of this protein. Here, we describe the cytosolic
protein nucleoredoxin as a novel interaction partner of the cyto-
solic domain of human Sec63. Nucleoredoxin (NRX or NXN) con-
tains three thioredoxin-like domains, the central one comprising
a catalytically active WCPPC motif. It interacts with protein phos-
phatase 2A and Dishevelled 1, the latter being a central component
of the Wnt signaling pathways [19–22].
2. Materials and methods
2.1. Materials
CHAPS was obtained from Calbiochem and ECL from GE Health-
care. Peroxidase coupled anti-penta-histidine antibodies were
from Qiagen and the peroxidase conjugates of anti-rabbit IgG-goat
antibodies were from Sigma. Recombinant derivatives of mouse
NRX with aminoterminal hexa-histidine tags and of human Sec63
with aminoterminal glutathione S-transferase (GST) tags were
puriﬁed from Escherichia coli as previously described [17,19].
2.2. Pull down assay
Puriﬁed GST or related hybrid proteins (10 lg) were immobi-
lized on GSH-sepharose. Then, buffer (20 mM HEPES–KOH,
pH 7.5, 150 mM KCl, 1 mM EDTA, 1.5 mM MgCl2, 0.65% CHAPS)
or puriﬁed hexa-histidine fusion protein (12 lg) in the same buffer
was applied to the resin. After washing, the bound material was
eluted and analyzed by SDS–PAGE, followed by protein staining
with Coomassie Brilliant Blue or Western blotting plus immunode-
tection with anti-penta-histidine antibodies coupled to peroxidase.
The blots were incubated in ECL and antibodies were visualized by
subsequent luminescence-imaging (Lumi-Imager F1 with LumiAn-
alyst software 3.1, Roche Diagnostics).
2.3. Peptide spot assay
Peptide spots that corresponded to NRX and Sec63C, respec-
tively, were synthesized on cellulose membranes according to an
established procedure [17,23]. The peptides consisted of 15 amino
acid residues with an overlap of 10 residues and were incubated
with 14C-labeled proteins in the above-mentioned buffer in the
presence or absence of H2O2 (5 mM). The bound proteins were
visualized by phosphorimaging (Typhoon Trio with Image Quant
TL software 7.0, GE Healthcare).3. Results
3.1. Sec63 interacts with NRX
We used the carboxy-terminal domain of human Sec63 (termed
Sec63C, amino acid residues 210–760) as bait in a two-hybrid
screening of a human placenta cDNA library (Fig. 1a, italic letters).
Among other proteins, we identiﬁed NRX as a putative interaction
partner. The smallest NRX fragment corresponded to residues 411–435 (Fig. 1b, italic letters), the largest fragment to residues
363–435 (Fig. 1b).
GST pull-down experiments were carried out to further sub-
stantiate the putative interaction. GST and various GST hybrid pro-
teins were immobilized on GSH sepharose and incubated with
hexa-histidine tagged NRX [19]. After washing the afﬁnity resin,
the bound material was eluted and analyzed by SDS–PAGE
followed by protein staining or immunoblotting with anti-penta-
histidine antibodies. The GST hybrid proteins contained GST at
the amino-terminus and the cytosolic domain of human Sec63
(Sec63C; amino acid residues 210–760) or fragments of Sec63C
at the carboxy-terminus. Some fragments contained or did not
contain the extremely negatively charged carboxy-terminus (ami-
no acid residues 734–760), corresponding to the Sec62 interaction
domain [17]. NRX did not bind to GST (Fig. 2a, lanes 2 and 3). How-
ever, NRX bound to Sec63C and this binding was more pronounced
when amino acid residues 734–760 were deleted, possibly mim-
icking the native situation where this domain is interacting with
Sec62 (Fig. 2a, lanes 4/5 and 7/8). Complementing this result,
NRX did not bind to amino acid residues 734–760 (Fig. 2a, lanes
9 and 10). Thus, the pull down experiments conﬁrmed the interac-
tion between human Sec63 and NRX that had originally been ob-
served in a yeast two-hybrid screen. Then, Sec63C lacking amino
acid residues 734–760 was further analyzed by dividing it into
three fragments (amino acid residues 210–508, 509–630, and
631–733). All three fragments showed the interaction, suggesting
multiple interaction sites in Sec63 (Fig. 2b).
3.2. Interaction of Sec63 with NRX is redox regulated
It was shown previously that the interaction of NRX with its
partner Dishevelled 1 (Dvl1) is redox regulated [19]; therefore,
we examined if this was also true for the NRX/Sec63 interaction.
Again, GST pull-down experiments were employed. First, the inter-
action between Sec63C and NRX was carried out under reducing
conditions, i.e. in the presence of DTT, which led to a reduced inter-
action (Fig. 2a, lane 6 versus 5). Next, the interaction was carried
out under oxidizing conditions, i.e. in the presence of H2O2. There
was an increase in the Sec63/NRX interaction in the presence of
H2O2. The H2O2 effect was most signiﬁcant in the Sec63C fragment
comprised of amino acid residues 509–630 (Fig. 2b, lane 11; Fig. 1a,
underlined letters).
Next, the effect of oxidizing conditions was quantitatively ana-
lyzed, i.e. increasing concentrations of H2O2 were used during
binding. There was a signiﬁcant increase in the Sec63/NRX interac-
tion with increasing concentrations of H2O2 (Fig. 2c, lanes 5–9).
However, H2O2 did not induce binding of NRX to GST (Fig. 2b
and c). Thus the Sec63/NRX interaction showed redox sensitivity,
particularly in the region between amino acid residues 509–630.
However, in contrast to the interaction between NRX and Dvl1,
the NRX/Sec63 interaction was stimulated by oxidative conditions.
3.3. Interaction of human Sec63 with NRX involves the central region
of Sec63C and the carboxy-terminus of NRX
Peptide spot experiments were carried out to further character-
ize the Sec63/NRX interaction. Peptide spots that corresponded to
NRX and Sec63C, respectively, were synthesized on cellulose mem-
branes according to an established procedure [23]. Subsequently,
the membranes were incubated with 14C-labeled GST-Sec63-509/
630 and NRX, respectively, under the conditions of the pull down
assay, i.e. in the presence and absence of H2O2. The bound proteins
were visualized by phosphorimaging (Fig. 3a and c) and plotted
against the respective peptides (Fig. 3b and d). Incubation of the
NRX spots with GST-Sec63-509/630 identiﬁed two regions as
dominant interaction sites (peptide spots 22–25 and 66–84
Fig. 1. Primary structures of human Sec63 and human nucleoredoxin. The amino acid sequences are given as single letter codes (accession numbers: NP_009145 and
NP_071908). The predicted transmembrane domains in Sec63 are shown in grey letters. Italics identify the smallest regions that showed an interaction in the yeast two-
hybrid screen, red letters characterize regions that showed interactions in the peptide spot assays, and the region of Sec63 that showed the most signiﬁcant interaction with
NRX in the pull down assay under oxidizing conditions is underlined. Structural analysis identiﬁed a Brl domain in the cytosolic domain of Sec63 that comprises a six-helix
bundle (amino acid residues 261–402), a helix-loop-helix fold (amino acid residues 415–476), and a seven-stranded immunoglobulin-like b-sandwich (amino acid residues
478–752) [26,27]; nucleoredoxin may contain three thioredoxin- or protein disulﬁde isomerase-like domains (underlined amino acid residues 11–165, 176–307, and 312–
427) [24,25].
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(Fig. 3a and b; highlighted by solid black bars in b). GST did not
bind to any of the NRX spots (Fig. 3a, upper panel). Incubation of
the Sec63C spots with NRX identiﬁed three regions as interaction
sites (peptide spots 14–20, 33–39, and 58–68 corresponding to
amino acid residues 275–319, 370–414, and 495–559) (Fig. 3c
and d; highlighted by solid black bars in d). Binding of NRX to these
three regions was increased under oxidizing conditions, thus
showing the redox sensitivity of the pull down experiments. Thus,
these results conﬁrmed the results from the pull-down experi-
ments and reproduced the presence of multiple interaction sites
at the level of Sec63, emphasizing the region between amino acid
residues 509–559 (Fig. 1a, red letters). Furthermore, these results
identiﬁed two interaction sites at the level of NRX (Fig. 1b, red
letters); one of these sites overlapped with the smallest fragment
originally identiﬁed in the yeast two-hybrid assay (Fig. 1b, italic
letters) and is part of the third thioredoxin-like domain (see
below). In addition, these results suggested that the redox effect
that was observed in the pull-down experiments occured at the
level of NRX. This interpretation is consistent with the fact that
the region of Sec63 that showed the most signiﬁcant interaction
with NRX in the pull down assay under oxidizing conditions is free
of any cysteine residues (Fig. 1a, underlined sequence).
4. Discussion
In the present work, we report a novel interaction of the human
protein Sec63 that may provide the so-far elusive link between
SEC63 mutations and PCLD. The interaction between Sec63 andNRX was ﬁrst observed in a yeast two-hybrid screen and involved
the cytosolic domain of the ER membrane protein Sec63. This
interaction was subsequently conﬁrmed and characterized by
pull-down and peptide-binding assays (summarized in Fig. 1).
Brieﬂy, the interaction involves the carboxy-terminus of NRX (ami-
no acid residues 411–430) that is part of the third putative thiore-
doxin- or protein disulﬁde isomerase-like domain of NRX (termed
b0 domain) [24,25], and the Brl2 domain at the level of Sec63, in
particular part of the seven-stranded immunoglobulin-like b-sand-
wich within the Brl2 domain (amino acid residues 509–559)
[26,27]. The b0 domain appears to represent a substrate binding do-
main of NRX and the Brl2 domain was characterized as a general
protein interaction platform.
NRX was previously shown to interact with Dishevelled 1, a
central component ofWnt signaling pathways [19]. This interaction
depends on the redox status of the cell. Under reducing conditions,
NRXbinds toDvl1 and suppresses theWnt/b-catenin signalingpath-
way; while under conditions of oxidative stress, the interaction is
prevented and Wnt/b-catenin signaling is activated. The NRX/
Sec63 interaction also showed redox sensitivity. However, in the
case of the NRX/Sec63 interaction the effect of oxidizing conditions
was opposite as compared to the NRX/Dvl1 interaction. Thus, oxida-
tive stress can be expected to favor Wnt/b-catenin signaling by
simultaneously inhibiting theNRX/Dvl1 interaction and stimulating
theNRX/Sec63 interaction, both suppressing complex formation be-
tween NRX and Dvl1.
The following is a possible scenario for the Sec63/NRX interac-
tion: the cytosolic domain of Sec63 provides a binding platform for
NRX and, therefore, affects the level of NRX that is available for
Fig. 2. Interaction between human Sec63 and nucleoredoxin. (a–c) GST or GST
hybrid proteins were immobilized on GSH-sepharose. Then, buffer or NRX in the
same buffer was applied to the resin. Where indicated DTT (2 mM) or H2O2 (5 mM if
not indicated otherwise) was present during binding. After washing, the bound
material was eluted and analyzed by SDS–PAGE followed by protein staining with
Coomassie Brilliant Blue or Western blotting plus immunodetection with anti-
penta-histidine antibodies coupled to peroxidase. The blots were incubated in ECL
and antibodies were visualized by subsequent luminescence-imaging. For Western
blots only the areas of interest are shown.
Fig. 3. Interactions between nucleoredoxin and Sec63. Peptide spots (15-mers,
overlapping by 10 amino acid residues) that corresponded to NRX (a, b) and Sec63C
(c, d), respectively, were synthesized on cellulose membranes. The membranes were
incubated with 14C-labeled GST or GST-Sec63-509/630 (a, b) or with 14C-labeled
NRX (c, d) in the presence or absence of H2O2 (5 mM). The bound proteins were
visualized by phosphorimaging (a, c) and plotted against the peptide spots (b, d).
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Wnt/b-catenin signaling pathway as well as cadherin controlled
cell–cell adhesion [21,22]. In addition, NRX is linked to the Wnt/
planar cell polarity pathway that is involved in cystogenesis in
ADPKD [20]. Previously, the second gene that is associated with
PCLD, PRKCSH, had been linked to cadherin [15]. Therefore, we sug-
gest there is a link between SEC63, PRKCSH and the Wnt/b-catenin
pathway, which should be taken into account as the common
denominator for the pathogenesis of ADPLD as well as the role of
the gene products in the biogenesis of secreted and plasma mem-
brane proteins. This suggestion is appealing because the etiologies
of ADPKD and ADPLD may be related. Recent work on ADPKD sug-
gested the Wnt/b-catenin signaling pathways may possibly link
the mutations in the PC1 and PC2 genes and that cyst formation
is due to problems in planar cell polarity and tubular morphogen-
esis [1]. The SEC63 gene was also found among the most frequently
mutated genes in cancers that had deﬁcient DNA mismatch repair,
including hereditary non-polyposis colorectal cancer (HNPCC)-
associated malignancies and sporadic cancers with frequent
microsatellite instability [28,29]. Deregulation of Wnt/b-cateninsignaling pathways is likely linked to various cancers due to alter-
ations in cell–cell adhesion and migration [21].
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